BREAST CANCER BREAKTHROUGH
Until now, hormonal treatment of breast cancer has been geared towards blocking oestrogen, often with unpleasant side effects. Now a global study involving researchers at The University of Adelaide found there may be another, less toxic, way to tackle the most common form of breast cancer. It was found that a drug called enobosarm stimulates an androgen receptor, making it effective against oestrogen receptor-positive breast cancer, which makes up 80 per cent
